ScholarIQanswers from OpenAlex
London Biofoundry
InstitutionResearch output, impact & collaborations
London Biofoundry is a institution indexed in ScholarIQ from OpenAlex.
What is known about London Biofoundry?
ScholarIQrecord summary
London Biofoundry is a research organisation in London, United Kingdom. OpenAlex records 452 works and 35,299 citations for it. 5 researchers list it as their most recent affiliation.
How many works does London Biofoundry have?
ScholarIQindexed works
London Biofoundry has 452 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does London Biofoundry have?
ScholarIQcitation count
London Biofoundry has 35,299 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at London Biofoundry?
ScholarIQresearcher count
London Biofoundry has 5 researchers in the ScholarIQ index.
What is the average h-index at London Biofoundry?
ScholarIQavg h-index
London Biofoundry has an average h-index of 78.4 in OpenAlex.
What is the ROR of London Biofoundry?
ScholarIQror
The ROR for London Biofoundry is on the source record.
What is the OpenAlex record for London Biofoundry?
ScholarIQopenalex
The OpenAlex for London Biofoundry is on the source record.
Who are the most-cited researchers behind London Biofoundry?
ScholarIQtop researchers by citations
What are the most-cited papers on London Biofoundry?
ScholarIQmost cited works
Endoscopist-Directed Administration of Propofol: A Worldwide Safety Experience
Douglas K. Rex, Viju P. Deenadayalu, Emely Eid, Thomas F. Imperiale, John Walker, Kuldip Sandhu, Anthony C. Clarke, Lybus Hillman, Akira Horiuchi, Lawrence B. Cohen, Ludwig T. Heuss, Shajan Peter, Christoph Beglinger, James A. Sinnott, Tom Welton, Magdy Z. Rofail, Iyad M. Subei, Rodger A. Sleven, Paul Jordan, John S. Goff, Patrick D. Gerstenberger, Harold Munnings, Martín Tagle, Brian Sipe, Till Wehrmann, Jack A. Di Palma, Kaitlin Occhipinti, Egidio Barbi, Andrea Riphaus, Stephen T. Amann, Gen Tohda, Timothy McClellan, Charles Thueson, JOHN LOVETT MORSE, Nizam M. Meah
Mendelian randomization for studying the effects of perturbing drug targets
Dipender Gill, Marios K. Georgakis, Venexia Walker, Amand F. Schmidt, Apostolos Gkatzionis, Daniel F. Freitag, Chris Finan, Aroon D. Hingorani, Joanna M. M. Howson, Stephen Burgess, Daniel I. Swerdlow, George Davey Smith, Michael V. Holmes, Martin Dichgans, Jie Zheng, Bruce M. Psaty, Neil M Davies
Genetically Determined Levels of Circulating Cytokines and Risk of Stroke
Marios K. Georgakis, Dipender Gill, Kristiina Rannikmäe, Matthew Traylor, Christopher D. Anderson, Jin‐Moo Lee, Yoichiro Kamatani, Jemma C. Hopewell, Bradford B. Worrall, Jürgen Bernhagen, Cathie Sudlow, Rainer Malik, Martin Dichgans
Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis
Emmanouil Bouras, Ville Karhunen, Dipender Gill, Jian Huang, Philip Haycock, Marc J. Gunter, Mattias Johansson, Paul Brennan, Timothy J. Key, Sarah J. Lewis, Richard M. Martin, Neil Murphy, Elizabeth A. Platz, Ruth C. Travis, James Yarmolinsky, Verena Zuber, Paul Martin, Michail Katsoulis, Heinz Freisling, Therese Haugdahl Nøst, Matthias B. Schulze, Laure Dossus, Rayjean J. Hung, Christopher I. Amos, Ari Ahola‐Olli, Saranya Palaniswamy, Minna Männikkö, Juha Auvinen, Karl‐Heinz Herzig, Sirkka Keinänen‐Kiukaanniemi, Terho Lehtimäki, Veikko Salomaa, Olli T. Raitakari, Marko Salmi, Sirpa Jalkanen, CRUK, BPC3, CAPS, PEGASUS, Marjo-Riitta Jarvelin, Abbas Dehghan, Konstantinos K. Tsilidis
Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side Effects
Dipender Gill, Marios K. Georgakis, Fotios Koskeridis, Lan Jiang, QiPing Feng, Wei‐Qi Wei, Evropi Τheodoratou, Paul Elliott, Joshua C. Denny, Rainer Malik, Εvangelos Εvangelou, Abbas Dehghan, Martin Dichgans, Ioanna Tzoulaki
How much of the research on London Biofoundry is open access?
ScholarIQopen access share
100%OPEN ACCESS